Gemcitabine and Pemetrexed in Primary Unknown Adenocarcinoma
Clinical trial NCT00191503 · COMPLETED
Trial details
- NCT number
- NCT00191503
- Sponsor
- Eli Lilly and Company
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2005-01-01
- Enrollment
- 30
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.